Literature DB >> 25696562

Intracoronary abciximab.

S Ruiz Bustillo, P Stella, P A F M Doevendans.   

Abstract

Here we report the potential benefits of the use of intracoronary abciximab during percutaneous coronary intervention for an acute myocardial infarction.

Entities:  

Keywords:  PCI; abciximab (intracoronary); myocardial infarction (acute); thrombus

Year:  2006        PMID： 25696562      PMCID： PMC2557316     

Source DB:  PubMed          Journal:  Neth Heart J        ISSN： 1568-5888            Impact factor:   2.380


  2 in total

1.  Increase of myocardial salvage and left ventricular function recovery with intracoronary abciximab downstream of the coronary occlusion in patients with acute myocardial infarction treated with primary coronary intervention.

Authors:  Francesco Bellandi; Mauro Maioli; Michela Gallopin; Anna Toso; Roberto Piero Dabizzi
Journal:  Catheter Cardiovasc Interv       Date:  2004-06       Impact factor: 2.692

2.  Comparison of intracoronary vs. intravenous administration of abciximab in coronary stenting.

Authors:  Aman K Kakkar; Ali Moustapha; Henry G Hanley; Mitchell Weiss; Gloria Caldito; Praphul Misra; Pratap C Reddy; Neeraj Tandon
Journal:  Catheter Cardiovasc Interv       Date:  2004-01       Impact factor: 2.692
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.